A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Gonanes
  • Neoplasms
  • Taxoids

abstract

  • Treatment with PX-866 and docetaxel was well tolerated, without evidence of overlapping/cumulative toxicity. Further investigation with this combination is justified.

publication date

  • September 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3778312

Digital Object Identifier (DOI)

  • 10.1038/bjc.2013.474

PubMed ID

  • 23942080

Additional Document Info

start page

  • 1085

end page

  • 92

volume

  • 109

number

  • 5